financetom
Business
financetom
/
Business
/
Brazil's Enauta, 3R agree to go ahead with proposed merger
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil's Enauta, 3R agree to go ahead with proposed merger
Apr 10, 2024 3:48 AM

SAO PAULO, April 10 (Reuters) - Brazilian energy

companies Enauta and 3R Petroleum have

signed a memorandum of understanding to go ahead with a proposed

merger unveiled earlier this month, according to a securities

filing on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Correction: NovaGold Resources Posts Q1 FY26 Loss On Higher Expenditures at Donlin Gold, Which Remains Its
Correction: NovaGold Resources Posts Q1 FY26 Loss On Higher Expenditures at Donlin Gold, Which Remains Its "Primary Focus" For 2026
Apr 1, 2026
08:56 AM EDT, 04/01/2026 (MT Newswires) -- NovaGold Resources ( NG ) (NG.TO, NG), a development-stage company with no production, on Wednesday posted a fiscal Q1 2026 net loss of US$0.04 a share, reflecting higher expenditures at the Donlin Gold project in Alaska, which remains its primary focus for 2026. The company said it held approximately $392.5 million in cash...
Cal-Maine Foods Quarterly Results Fall Amid Lower Egg Prices; Expects Earnings to Stabilize
Cal-Maine Foods Quarterly Results Fall Amid Lower Egg Prices; Expects Earnings to Stabilize
Apr 1, 2026
08:54 AM EDT, 04/01/2026 (MT Newswires) -- Cal-Maine Foods ( CALM ) fiscal third-quarter results fell year over year amid lower egg prices, although the company expects earnings to stabilize in the long term. The egg producer on Wednesday posted net income of $1.06 a share for the three-month period ended Feb. 28, down 90% from a year earlier. The...
Cogent Biosciences Submits New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors in US
Cogent Biosciences Submits New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors in US
Apr 1, 2026
08:54 AM EDT, 04/01/2026 (MT Newswires) -- Cogent Biosciences ( COGT ) said Wednesday it submitted a new drug application to the US Food and Drug Administration for bezuclastinib to treat gastrointestinal stromal tumors in patients previously treated with imatinib. The application was submitted under the FDA's Real-Time Oncology Review program based on positive results from a phase 3 trial,...
Jukebox Health Acquires Braided Health to Expand AI-Driven Integrated Care Platform for High-Needs Duals
Jukebox Health Acquires Braided Health to Expand AI-Driven Integrated Care Platform for High-Needs Duals
Apr 1, 2026
Augments Jukebox Health's home safety and independence ecosystem to help Managed Care Organizations modernize legacy care management systems and lower total cost of care for high-need, dual-eligible populations. NEW YORK, April 1, 2026 /PRNewswire/ -- Jukebox Health, a leader in advancing safety and independence at home, today announced the acquisition of Braided Health, a care management technology company serving high-need,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved